Screener

Segment Operating Income Loss

Name: Gyre Therapeutics, Inc. Segment Operating Income Loss by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Gyre Therapeutics, Inc.·Business Segments·2 segments

Breakdown

Segment	Q2 '26
Gyre	-$8.69M
Gyre Pharmaceuticals	-$5.67M
Total	-$5.67M

Segments

Gyre PharmaceuticalsView metric

GyreView metric